Memphasys Ltd

MEM

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

Are there signs of an AI bubble in Nvidia’s earnings?

Our view after third-quarter results.
stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

With outstanding long-term estimates, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,686.308.30-0.10%
CAC 407,989.448.370.10%
DAX 4023,091.87186.98-0.80%
Dow JONES (US)46,245.41493.151.08%
FTSE 1009,531.013.360.04%
HKSE25,220.02615.55-2.38%
NASDAQ22,273.08195.030.88%
Nikkei 22548,625.881,198.06-2.40%
NZX 50 Index13,419.4020.00-0.15%
S&P 5006,602.9964.230.98%
S&P/ASX 2008,416.500.000.00%
SSE Composite Index3,834.8996.16-2.45%

Market Movers